# Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

> **NCT05429515** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Myeloma
- Acute Kidney Injury
- Hemodiafiltration With Ultrafiltrate Regeneration (HFR)

## Interventions

- **PROCEDURE:** HFR-SUPRA
- **PROCEDURE:** hemodialysis
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT05429515
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2032-07-01
- **Final completion:** 2032-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429515, "Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05429515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*